Search

everythinglearnresearchcommunity

for

Search:↓

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Inflammation and immunity play a key role in androgenetic alopecia, with better treatment outcomes in certain immune-positive cases.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Live imaging helps us understand skin immune responses and develop treatments.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

IL-18 signaling helps mature Tregs move into the thymus.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Natural killer cells play a key role in autoimmune skin diseases like pemphigus vulgaris.

More precise, personalized therapies are needed for autoimmune diseases.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

SII is a useful and affordable tool to assess and monitor alopecia areata.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Innate lymphoid cells help us understand and manage allergic diseases better.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Immunological skin diseases in pigs are rare and can be caused by immune system issues or external factors.